Several mapping studies of families with multiple individuals who have bipolar affective disorder (BPAD) have demonstrated possible linkage of the trait to the pericentric region of chromosome 18 (18cen). Currently, the large size of the critical interval defined by these studies makes effective selection of candidate genes formidable. However, documentation of 18cen-linked families in which a parent-of-origin effect was observed in the transmission of the BPAD trait provides a clue to the nature of the putative gene; it may be imprinted. In the present study, we cloned IMPACT, the human homolog of the mouse imprinted gene Impact and mapped it to 18cen within the critical interval for BPAD. Human IMPACT encodes a protein with 320 amino acids and is expressed at high levels in the brain. Since only a small number of imprinted genes are estimated to be present in the entire genome, very few imprinted genes would be expected to be present in this particular chromosomal region. Hence, IMPACT represents a candidate gene for BPAD susceptibility. Alternatively, other as yet unknown imprinted gene(s) adjacent to IMPACT could contribute to the BPAD trait, since multiple imprinted genes may occasionally form clusters. Localization of human IMPACT at 18cen in this study defines a promising target region in which to search for putative BPAD genes. Molecular Psychiatry (2001) 6, 87-91.
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Bipolar affective disorder (BPAD) is characterized by a change of mood to depression or elation and is considered to be a multifactorial disease with a lifetime prevalence of 1%. 1 Increased risk of BPAD in relatives of an affected proband provides strong evidence for a major genetic contribution to the pathogenesis of BPAD. Families with multiply affected individuals further suggest a major role for a genetic component in determining susceptibility. Familial studies have suggested linkage to chromosomes 4, 2 12, 3 18, 4-7 and 21.
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A recent high-density genome scan indicated linkage to the pericentric region of chromosome 18. 9 However, several studies have yielded negative or ambiguous results regarding the linkage of BAPD to chromosome 18. [10] [11] [12] [13] [14] Even in the studies in which positive linkage was suggested, the large size of the critical interval defined by these studies makes effective selection of candidate genes a formidable task.
To better characterize and refine the candidate region, we took advantage of the fact that transmission suggestive of genomic imprinting is observed in a subset of families linked to the pericentric region of chromosome 18.
15-18 Because a limited number of genes are imprinted in the whole genome, very few imprinted genes are expected to be present at 18cen. Hence, such imprinted genes would be good candidates for BPAD susceptibility, at least among families with transmission patterns compatible with imprinting.
In the process of systematic mapping and cloning of human homologs of mouse imprinted genes, we mapped the human homolog of mouse imprinted gene Imprinted and ancient (Impact) 19 at human 18cen. Considering that most of the human homologs of mouse imprinted genes are also imprinted in humans, characterization of the human homolog of Impact would help to delineate the putative BPAD susceptibility gene(s) at 18cen. We herein report the cloning and mapping of the human IMPACT gene which represents a candidate for susceptibility to BPAD.
Impact is referred to as such because it has imprinted expression 19 and is phylogenetically ancient. 20 The cDNA sequence of the human homolog of the mouse Impact gene was determined by a combination of in silico methods and PCR cloning. Two human bacterial artificial chromosome (RPCI-11-178F10 and 10L24; BACPAC Resources, Oakland, CA, USA) sequences (GenBank accession numbers AC007922 and AC009668) were demonstrated to be highly homologous to the mouse Impact cDNA (GenBank accession number D87973) through a database search of the GenBank. The entire coding sequence of the human transcript was inferred by cross-examination of the genomic and the cDNA sequences ( Figure 1 ). To verify the authenticity of the hypothetical transcript, RT-PCR was performed with primers IPCT36 (AATGGCAGC CATTTATGGCGAGG) and IPCT26 (CTCCTATT CCAATAAGCCATAAAGAGCAG) and an aliquot of cDNA reverse-transcribed from brain tissue of a 19-week fetus. The sequences of RT-PCR products com- pletely coincided with that of the hypothetical transcript inferred from the genomic sequence.
The cDNA sequence contained an open reading frame of 320 amino acids ( Figure 2 ). The predicted peptide sequence of this open reading frame showed a high degree of homology to that of mouse Impact with 83% identity and 92% similarity ( Figure 3 ). We designated the human homolog of the mouse Impact gene as IMPACT. The entire coding sequence for the IMPACT gene was contained in the RPCI-11 BAC clone 178F10 ( Figure 1 ). There are 11 exons (Table 1) and the intron/exon boundaries all follow the GT/AG rule, where GT is the spliced donor and AG is the splice acceptor. Primer pairs to amplify each exon are available from the author upon request. A T to G single nucleotide polymorphism (SNP), which creates a Fnu4H I and Aci I site, was found 272 bp upstream of the putative start codon. This SNP was detected by sequencing the PCR products of 10 normal individuals with the primers IPCT5 (CCGCAATGGGCAAGCAAA AGC) and IPCT35 (AAAATGGAACGCGGTGGAGCA AATG). A tandem repeat of 30 bp, TTGTTCTGG CTGAAATGAAAATAGGACTGA-TTGTTCTGGCTGAAG TGAAA ATAGGACTGA was found in the 5Ј region 2 kb upstream from the putative start codon. The presence of a direct tandem repeat in the 5Ј region is considered to be a common feature of imprinted genes. 21 Radiation hybrid mapping with the Stanford G3 panel 22 (Research Genetics, Huntsville, AL, USA) and the primers IPCT25 (ATTTCATCTTTATGTAAATGG AGAGATGCTGCAC) and IPCT28 (GCTAAAATTAGA TGAAGTGGTGATTAAGTTCAAATTAGTTC), which encompass exon 11 (Figure 1) , revealed a significant LOD score of 13.06 to the D18S480 locus which is mapped to 18p11.1-p11.2 (The Genome Database, http://www.gdb.org).
The pattern of expression of human IMPACT was examined by RT-PCR using a pair of primers, IPCT30 (CTTCTTACAGGATTGTGAGGATGATGG) and IPCT28, and a panel of extracts from various human cDNA libraries (the Express Check kit, ATCC, Manassas, VA, USA). IMPACT was amplified from 23-week fetal brain, 1-day-old basal ganglia, tonsil, and B-lymphocytes. Expression of the human IMPACT gene in the brain and in the lymphoid tissues was comparable to the mouse Impact gene, which is expressed most abundantly in the brain and lymphocytes. 19 Given the evolutionary conservation of imprinting among vertebrate species, and presence of direct repeats in the 5Ј region, human IMPACT is likely to be imprinted. Mapping of the human homolog of the mouse imprinted gene Impact to the pericentric region of chromosome 18 region supports the notion that the region may be imprinted. However, there are a few exceptional genes that are imprinted in the mouse but not in humans. U2AFBPL, the human homolog of mouse U2af1-rs1 which is expressed from the paternal allele only, is expressed from both parental alleles in humans. 23 Another example is the insulin-like growth factor II receptor that is imprinted in the mouse but not in humans. 24 In view of these two exceptional genes, parent-of-origin specific expression of IMPACT awaits verification.
There is now a growing list of imprinted genes which when mutated alter behavioral patterns. Examples include SNRPN in Prader-Willi syndrome, UBE3A in Angelman syndrome. 25 Furthermore, putative imprinted transmission of autism at 7q32 region is reported. 28 Mice deficient for imprinted genes, Peg1 26 and Peg3, 27 exhibit abnormal behavior as well. 28 It is possible that human IMPACT itself, expressed highly in the brain, is directly involved in the pathogenesis of BPAD. Linkage studies using the SNP at the 5Ј end of IMPACT, which was identified in the present study, should help to clarify whether IMPACT is linked. It is equally possible that other yet unknown imprinted gene(s) neighboring IMPACT, if any, could contribute to the BPAD trait, considering that multiple imprinted genes, in many cases, exist in a confined interval in a cluster. 29 G-olf alpha (GNAL), which encodes a subunit of a Gprotein involved in intracellular signaling, represents 30 (2) it is expressed in the brain; (3) it couples to dopamine receptors; and (4) G-proteins in general can be modulated by lithium salts, 31 which are therapeutically used for BPAD. It is particularly intriguing to note that a positive linkage to pericentric chromosome 18 markers was documented among BPAD families responsive to lithium. 7 Among the families with linkage to the pericentric region of chromosome 18, the BPAD trait was transmitted paternally in some pedigrees 32 and maternally in others. 7, 16 The apparent lack of consistency in parental origin among different families of BPAD 15, 16 could be accounted for by any of the following mechanisms: (1) Two or more imprinted genes are involved Molecular Psychiatry in the pathogenesis of BPAD, some paternally expressed and others maternally expressed. Examples of such reciprocally imprinted genes in close proximity include IGF2 and H19 on chromosome 11p. 33, 34 (2) Two transcripts, alternatively transcribed from a single locus, could be reciprocally imprinted, like GNAS1 and NESP55 at the GNAS locus on chromosome 20. 35, 36 (3) It is possible that data indicating a positive linkage between BPAD and markers in 18cen with a parent-oforigin effect could represent an artifact (ie falsepositive) as suggested by several studies. [10] [11] [12] [13] [14] In conclusion, we have identified IMPACT, the human ortholog of the mouse Impact gene, and mapped it to the pericentric region of chromosome 18. Together with the linkage data, localization of human IMPACT at 18cen in this study defines a target region in which to search for imprinted genes which may represent BPAD susceptibility genes.
Methods
Tissue samples and RNA synthesis Human brain tissue was obtained from the Research Resource Bank with the permission of the Ethics Committee at the National Center of Neurology and Psychiatry. Total RNA was extracted from brain with a commercial kit (Qiagen, Valencia, CA, USA) and was treated with RNase-free DNase (Gibco/BRL, Rockville, MD, USA). Then, complementary DNA (cDNA) was directly synthesized using a SuperScript II amplification kit (Gibco/BRL) with the oligo dT primer. The recommended protocols from the manufacturers were followed.
Sequence analysis
Sequence data were obtained from the GenBank (http://www.ncbi.nlm.nih.gov/Web/GenBank). Homology 37 and output was processed using the SeqVu program (Garvan Institute of Medical Research, Sydney, Australia). The accession number of mouse Impact homolog cDNA sequences used in this study is D87973. Tandem repeats in the genomic sequences were analyzed by the Tandem Repeats Finder program (http://c3.biomath. mssm.edu/trf.html). 38 
PCR and sequencing
Amplification was carried out in a 20-l reaction volume containing 1 l of reverse transcription product, 1 × reaction buffer, 200 M dNTP mix, 1.5 mM MgCl 2 , 10 nmoles of each primer, and 0.25 U Taq Gold polymerase (Perkin-Elmer, Foster City, CA, USA) with or without 5% DMSO. Reaction conditions were denaturation at 95°C for 10 min, followed by 35 cycles at 95°C for 60 s, 58°C for 60 s, and 72°C for 60 s, and a final extension step of 72°C for 10 min, if not otherwise indicated.
PCR products were sequenced with fluorescent dideoxy chain terminators and the BigDye terminator (Perkin Elmer) using 25 cycles of 95°C for 30 s, 58°C for 15 s, and, 60°C for 4 min and analyzed on an ABI 310 automated DNA sequencer (Perkin Elmer).
Radiation hybrid mapping of the human IMPACT gene
The chromosomal location of IMPACT was determined using a PCR-based approach with the primers IPCT25 5Ј 3Ј and IPCT28 5Ј 3Ј on the G3 radiation hybrid mapping panel (Research Genetics, Huntsville, AL, USA). The primers correspond to sequences predicated to flank exon 11 and generate a PCR product under the following conditions: 95°C for 60 s, 58°C for 60 s and 72°C for 60 s for 35 cycles in the presence of 200 M dNTP mix, 0.2 units of Taq Gold polymerase (PerkinElmer). The data were submitted to the Stanford Human Genome Center (http://www-shgc.stanford. edu/rhserver2/rhserver-form.html).
The human IMPACT cDNA sequence has been deposited in GenBank, accession number AF208694.
